Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 09, 2025
Astraveus SAS announced the successful end-to-end production of CAR-T cells within a microfluidic benchtop system. Astraveus has been able to demonstrate the potential of its unique microfluidic cell therapy processing approach, which has the ability...
read more
Thursday, January 09, 2025
Biofidelity and CellCarta announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials. Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analyzing both...
read more
Tuesday, January 07, 2025
ActiGraph has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry. The combined solution will create a market-leading, unified software ...
read more
Tuesday, January 07, 2025
Platinum Press, Inc., a provider of printed packaging solutions for the pharmaceutical, natural health and consumer products industries specializing in labels, folding cartons, leaflets, foil lidding and flexible packaging, has completed a $15 ...
read more
Tuesday, January 07, 2025
Gaelic Laboratories has established a Commercial Arm in the UAE that enables the company to import, register, market and distribute medicines in the Middle East. With its newly opened Gaelic Drug Store LLC in Dubai, the company now has an ...
read more
Tuesday, January 07, 2025
ProBioGen announced the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for proteins as well as the completion of the construction phase of...
read more
Axcelead Drug Discovery Partners, Inc. has entered into a drug discovery service agreement with Astellas Pharma, Inc. to explore new candidate compounds for targeted protein degraders.
read more
Thursday, January 02, 2025
Innovent Biologics, Inc. announced a collaboration and exclusive license agreement with Roche to advance the development of IBI3009, a novel DLL3-targeted antibody drug conjugate (ADC) candidate. IBI3009 has already obtained IND approvals in ...
read more
Thursday, January 02, 2025
GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the number of GMP-grade iPS cells manufactured has reached 100 lines.
read more
Thursday, January 02, 2025
Porton Pharma Solutions and Dragon Sail Pharmaceutical Co., Ltd. signed a strategic cooperation agreement in Guilin, southern of China. This collaboration aims to carry out in-depth cooperation in the research, development, production, and supply ...
read more
Thursday, January 02, 2025
Veeda Group has unveiled a new logo and brand identity - Veeda Lifesciences. The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise for different modalities of ...
read more
Thursday, December 19, 2024
Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced the establishment of a U.S.-...
read more
Thursday, December 19, 2024
Catalent, Inc. and Novo Holdings A/S announced that Novo Holdings has completed its previously announced acquisition of Catalent in an all-cash transaction with a total enterprise value of approximately $16.5 billion.
read more
Thursday, December 19, 2024
Aramis Biotechnologies Inc. and Biodextris Inc. announced a strategic partnership that will leverage the expertise of both companies to ensure efficient downstream manufacturing of clinical materials for Aramis' leading product candidate, a seasonal ...
read more
Thursday, December 19, 2024
Accelerated Biosciences and Stemmatters announced their strategic partnership aimed at co-developing and co-marketing human induced pluripotent stem cells (“iPSC”) derived from human trophoblast stem cells (“hTSC”).
read more